5,176 transcripts
Page 48 of 100
u7i
Earnings call transcript
NASDAQ
2024 Q2
30 Jul 24
report on Form 10-K and other periodic reports.
Investors, potential investors and other listeners are urged to consider these factors carefully
og
Earnings call transcript
NASDAQ
2024 Q2
30 Jul 24
to a variety of factors. For a full discussion of these risk factors, please refer to our latest Form 10-K and our other SEC filings. We undertake
yfwm
Earnings call transcript
NASDAQ
2024 Q2
30 Jul 24
. Please refer to our most recent earnings release as well as our fiscal year 2023 10-K and other filings for a more detailed discussion of risks
57e
Earnings call transcript
NYSE
2024 Q2
30 Jul 24
, 10-K and subsequent filings pertaining to forward-looking statements.
Also during the call, we will be using some non-GAAP numbers, which
ztu8
Earnings call transcript
NASDAQ
2024 Q2
30 Jul 24
subject to a number of risks and uncertainties. Please refer to our Form 10-K and our Form 10-Q to be filed later today for a list of factors that could
10
Earnings call transcript
NASDAQ
2024 Q2
30 Jul 24
materially from those projected in such forward-looking statements. These risks and uncertainties are detailed in IPG Photonics Form 10-K
ra1
Earnings call transcript
NYSE
2024 Q4
30 Jul 24
contained in our annual report on Form 10-K for the year ended July 1, 2023, subsequent SEC filings and in the news release issued earlier
my
Earnings call transcript
NYSE
2024 Q2
30 Jul 24
to future risks and uncertainties, such as those factors described in Xylem's most recent annual report on Form 10-K and in subsequent reports filed
fca
Earnings call transcript
NYSE
2024 Q2
30 Jul 24
in the forward-looking statements.
Our SEC filings, including Item 1A and the 2023 10-K, identify certain risk factors and cautionary statements
28qb
Earnings call transcript
NYSE
2024 Q2
30 Jul 24
of risks and uncertainties, including those discussed in our most recent Form 10-K and 10-Q filings with the Securities and Exchange Commission that could
5nm
Earnings call transcript
NYSE
2024 Q2
30 Jul 24
Commission, including our most recently filed Form 10-K.
In today's press release and during the conference call, we're providing non-GAAP adjusted
rdyb
Earnings call transcript
NASDAQ
2024 Q2
30 Jul 24
risks related to our business is included in our quarterly reports on Form 10-Q, our annual report on Form 10-K and other current reports on 8-K
cln
Earnings call transcript
NYSE
2024 Q2
30 Jul 24
the risk factors set forth in this morning's earnings press release, those set forth in our most recent annual report on Form 10-K and other risks
frsg
Earnings call transcript
NYSE
2024 Q4
30 Jul 24
a number of forward-looking statements. If you will refer to P&G's most recent 10-K, 10-Q and 8-K reports, you will see a discussion of factors
jvr
Earnings call transcript
NYSE
2024 Q2
30 Jul 24
in these statements. We believe that these factors are described in the Risk Factors section contained in PJT Partners' 2023 Form 10-K, which is available
ll4
Earnings call transcript
NYSE
2024 Q2
30 Jul 24
our financial results is included in our Form 10-K for the year ended December 31, 2023, and our Form 10-Q for the quarter ended March 31, 2024
xn2
Earnings call transcript
NYSE
2024 Q2
30 Jul 24
be found in our earnings press release and in our filings with the SEC, including our most recent report on Form 10-K and 10-Q.
In addition, we
5cm
Earnings call transcript
NASDAQ
2024 Q4
30 Jul 24
, matters that we have described in our most recent annual report on Form 10-K and in other filings we make with the SEC. We disclaim any obligation
0x7
Earnings call transcript
NYSE
2024 Q2
30 Jul 24
on Form 10-K and quarterly reports on Form 10-Q as well as in other filings with the SEC. I encourage all of you to review the risk factors listed
spjv
Earnings call transcript
OTC
2024 Q2
30 Jul 24
2024 Form 10-Q filed today and in the risk factors and forward-looking statement sections in the company's 2023 Form 10-K filed on February 15, 2024